5 Years with Synchron Brain Implant

🔑 Enhanced Key Takeaways

• •Synchron's Stentrode device is implanted endovascularly via the jugular vein into a blood vessel near the motor cortex, using 16 electrodes to record neural signals without open brain surgery.[1][3][4]
• •As of late 2024, Synchron has implanted its BCI in 10 patients across the US and Australia since 2019, with the COMMAND trial showing no device-related serious adverse events in six patients over one year.[2][3]
• •The company, founded in 2012 by Professors Tom Oxley and Nicholas Opie from the University of Melbourne, received the first FDA investigational device exemption for a permanently implanted BCI trial.[2][4]

🛠️ Technical Deep Dive

• •Stentrode is a stent-like device with 16 metal electrodes deployed in a brain blood vessel near the motor cortex, inserted through a neck vein incision and positioned endovascularly.[1][3][4]
• •Uses digital motor output (DMO) to capture brain signals related to motor intent and convert them into actions on computers or devices.[1][2]
• •Wireless transmission via chest subcutaneous antenna; median deployment time of 20 minutes with 100% accurate motor cortex coverage in COMMAND study.[2]

🔮 Future ImplicationsAI analysis grounded in cited sources

⏳ Timeline